Lymphoma, Follicular
Oncology·MeSH: Lymphoma, Follicular
Prevalence
56.0 / 100K
Incidence
19.6 / 100K/yr
1 drug in development·1 company·2 clinical trials
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| ADI-001 | Adicet Bio, Inc. (ACET) |
Frequently asked questions
How many drugs are in development for Lymphoma, Follicular?
BioSniper tracks 1 drug in development for Lymphoma, Follicular across 1 company.
How many clinical trials target Lymphoma, Follicular?
There are 2 clinical trials targeting Lymphoma, Follicular tracked by BioSniper.
What is the prevalence of Lymphoma, Follicular?
The estimated prevalence of Lymphoma, Follicular is approximately 56.0 per 100,000 population.
Deep-dive into Lymphoma, Follicular
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis